Demystifying pulmonary fibrosis.
作者信息
Jenkins Gisli
机构信息
National Institute for Health Research, Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom.
出版信息
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L554-L559. doi: 10.1152/ajplung.00365.2020. Epub 2020 Aug 5.
Abstract
摘要
相似文献
1
Demystifying pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L554-L559. doi: 10.1152/ajplung.00365.2020. Epub 2020 Aug 5.
2
Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):E2048-57. doi: 10.1073/pnas.1415111112. Epub 2015 Apr 6.
3
[The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Sep;37(9):664-70.
4
USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
Discov Med. 2024 Aug;36(187):1616-1626. doi: 10.24976/Discov.Med.202436187.148.
5
13-Methylpalmatine alleviates bleomycin-induced pulmonary fibrosis by suppressing the ITGA5/TGF-β/Smad signaling pathway.
Phytomedicine. 2025 May;140:156545. doi: 10.1016/j.phymed.2025.156545. Epub 2025 Mar 1.
6
The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis.
Int J Mol Sci. 2018 Nov 15;19(11):3611. doi: 10.3390/ijms19113611.
7
SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis.
J Transl Med. 2024 Oct 1;22(1):885. doi: 10.1186/s12967-024-05698-3.
8
Comparative study of transforming growth factor-β signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis.
J Comp Pathol. 2014 May;150(4):399-407. doi: 10.1016/j.jcpa.2013.12.001. Epub 2013 Dec 10.
9
Profibrotic role of WNT10A via TGF-β signaling in idiopathic pulmonary fibrosis.
Respir Res. 2016 Apr 12;17:39. doi: 10.1186/s12931-016-0357-0.
10
The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation.
FASEB J. 2024 Oct 15;38(19):e70077. doi: 10.1096/fj.202302405RR.
引用本文的文献
1
CompCorona: A web application for comparative transcriptome analyses of coronaviruses reveals SARS-CoV-2-specific host response.
Turk J Biol. 2023 Dec 15;47(6):393-405. doi: 10.55730/1300-0152.2673. eCollection 2023.
2
Longitudinal x-ray based lung function measurement for monitoring Nintedanib treatment response in a mouse model of lung fibrosis.
Sci Rep. 2023 Oct 30;13(1):18637. doi: 10.1038/s41598-023-45305-x.
3
Targeting ATP12A, a Nongastric Proton Pump α Subunit, for Idiopathic Pulmonary Fibrosis Treatment.
Am J Respir Cell Mol Biol. 2023 Jun;68(6):638-650. doi: 10.1165/rcmb.2022-0264OC.
4
What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study.
Occup Environ Med. 2023 Feb;80(2):97-103. doi: 10.1136/oemed-2022-108404. Epub 2023 Jan 12.
5
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs.
Front Pharmacol. 2022 Jan 5;12:805535. doi: 10.3389/fphar.2021.805535. eCollection 2021.
6
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Transl Res. 2022 Mar;241:13-24. doi: 10.1016/j.trsl.2021.09.001. Epub 2021 Sep 20.
7
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
Nat Commun. 2021 Jul 14;12(1):4314. doi: 10.1038/s41467-021-24467-0.
8
Age-Related Dynamics of Lung-Resident Memory CD8 T Cells in the Age of COVID-19.
Front Immunol. 2021 Mar 29;12:636118. doi: 10.3389/fimmu.2021.636118. eCollection 2021.
9
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
EBioMedicine. 2021 Mar;65:103277. doi: 10.1016/j.ebiom.2021.103277. Epub 2021 Mar 10.
10
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
bioRxiv. 2021 Jan 4:2020.10.20.347187. doi: 10.1101/2020.10.20.347187.
本文引用的文献
1
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.
Commun Biol. 2021 Mar 23;4(1):392. doi: 10.1038/s42003-021-01910-y.
2
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3.
3
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1656-1665. doi: 10.1164/rccm.202007-2794OC.
4
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
Thorax. 2020 Oct;75(10):864-869. doi: 10.1136/thoraxjnl-2019-214478. Epub 2020 Jul 13.
5
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
Am J Trop Med Hyg. 2020 Jul;103(1):69-72. doi: 10.4269/ajtmh.20-0375. Epub 2020 May 21.
6
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
7
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Lancet Respir Med. 2020 Aug;8(8):807-815. doi: 10.1016/S2213-2600(20)30225-3. Epub 2020 May 15.
8
Remdesivir in covid-19.
BMJ. 2020 Apr 22;369:m1610. doi: 10.1136/bmj.m1610.
9
A potential role for integrins in host cell entry by SARS-CoV-2.
Antiviral Res. 2020 May;177:104759. doi: 10.1016/j.antiviral.2020.104759. Epub 2020 Mar 1.
10
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2020 May 15;201(10):1240-1248. doi: 10.1164/rccm.201908-1571OC.
Zotero 插件